Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study (Q42977630)
Jump to navigation
Jump to search
scientific article published on 10 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study |
scientific article published on 10 February 2012 |
Statements
1 reference
Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study (English)
1 reference
Stefan Zeuzem
1 reference
Tawesak Tanwandee
1 reference
Satawat Thongsawat
1 reference
Christophe Moreno
1 reference
Thomas Berg
1 reference
Hans Van Vlierberghe
1 reference
Oliver Lenz
1 reference
Monika Peeters
1 reference
Vanitha Sekar
1 reference
Goedele De Smedt
1 reference
10 February 2012
1 reference
1 reference
Identifiers
1 reference